US Biomax, Inc.

BR2001

Breast cancer high-density tissue array, 196 cases/200 cores, replaced by BR2086

Microarray Panel:Breast cancer microarray, single core of 192 cases of cancer in various stages and 8 cases of normal tissue (matched or unmatched)
Cores:200
Cases:196
Layout:16 cols × 13 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Proliferating Cell Nuclear Antigen (PCNA) confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Notes Image Type †
A1 1 F 49 Breast Intraductal carcinoma TisN0M0 Malignant
A2 2 F 41 Breast Intraductal carcinoma TisN0M0 Malignant
A3 3 F 48 Breast Intraductal carcinoma TisN0M0 Malignant
A4 4 F 50 Breast Fibrofatty tissue Malignant
A5 5 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I TxN0M0 Malignant
A6 6 F 32 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1N0M0 Malignant
A7 7 F 40 Breast Breast tissue Malignant
A8 8 F 54 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I TxN0M0 Malignant
A9 9 F 39 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
A10 10 F 44 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N3M0 Malignant
A11 11 F 40 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
A12 12 F 58 Breast A little carcinoma tissue TisN0M0 Malignant
A13 13 F 39 Breast Breast tissue Malignant
A14 14 F 36 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1N0M0 Malignant
A15 15 F 45 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
A16 16 F 44 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B1 17 F 45 Breast Chronic inflammation of fibrous tissue Malignant
B2 18 F 41 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) with necrosis II T3N0M0 Malignant
B3 19 F 60 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1N0M0 Malignant
B4 20 F 47 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B5 21 F 51 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I TisN0M0 Malignant
B6 22 F 40 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B7 23 F 55 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B8 24 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B9 25 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B10 26 F 31 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1N0M0 Malignant
B11 27 F 41 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2NxM0 Malignant
B12 28 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B13 29 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) with necrosis I T2NxM0 Malignant
B14 30 F 41 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2NxM0 Malignant
B15 31 F 44 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
B16 32 F 45 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
C1 33 F 49 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
C2 34 F 40 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C3 35 F 48 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C4 36 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C5 37 F 62 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C6 38 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1N0M0 Malignant
C7 39 F 47 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C8 40 F 58 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C9 41 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1micN0M0 Malignant
C10 42 F 42 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) with necrosis II T2N0M0 Malignant
C11 43 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1N0M0 Malignant
C12 44 F 27 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) with necrosis II T2N0M0 Malignant
C13 45 F 48 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C14 46 F 67 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
C15 47 F 32 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II TxN0M0 Malignant
C16 48 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D1 49 F 50 Breast Fibrocystic disease of breast Malignant
D2 50 F 52 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
D3 51 F 54 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
D4 52 F 40 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) with nercosis II T2N0M0 Malignant
D5 53 F 35 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II TxN0M0 Malignant
D6 54 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D7 55 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D8 56 F 57 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D9 57 F 44 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D10 58 F 30 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1N0M0 Malignant
D11 59 F 47 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
D12 60 F 53 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D13 61 F 60 Breast Chronic inflammation of fibrous tissue Malignant
D14 62 F 49 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T3N2M0 Malignant
D15 63 F 51 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
D16 64 F 51 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E1 65 F 52 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1cN0M0 Malignant
E2 66 F 64 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E3 67 F 60 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1cNxM0 Malignant
E4 68 F 64 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
E5 69 F 82 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) with neuroendocrine differentiation TxN0M0 Malignant
E6 70 F 53 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E7 71 F 67 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
E8 72 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
E9 73 F 45 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E10 74 F 37 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E11 75 F 48 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E12 76 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
E13 77 F 75 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
E14 78 F 53 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N1M0 Malignant
E15 79 F 48 Breast Medullary carcinoma T2N0M0 Malignant
E16 80 F 40 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
F1 81 F 57 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1NxM0 Malignant
F2 82 F 48 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
F3 83 F 59 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
F4 84 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
F5 85 F 70 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
F6 86 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
F7 87 F 35 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T3NxM0 Malignant
F8 88 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
F9 89 F 69 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T1NxM0 Malignant
F10 90 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1NxM0 Malignant
F11 91 F 60 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
F12 92 F 36 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N1M0 Malignant
F13 93 F 54 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
F14 94 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1NxM0 Malignant
F15 95 F 75 Breast Breast tissue T3N1M0 Malignant
F16 96 F 47 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
G1 97 F 49 Breast A little carcinoma tissue T2NxM0 Malignant
G2 98 F 79 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
G3 99 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
G4 100 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T4NxM0 Malignant
G5 101 F 54 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) III T2NxM0 Malignant
G6 102 F 49 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2NxM0 Malignant
G7 103 F 45 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
G8 104 F 48 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
G9 105 F 58 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
G10 106 F 34 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
G11 107 F 49 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) III T2NxM0 Malignant
G12 108 F 54 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T1N0M0 Malignant
G13 109 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T3NxM0 Malignant
G14 110 F 66 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T3NxM0 Malignant
G15 111 F 48 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
G16 112 F 39 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H1 113 F 38 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) III T2NxM0 Malignant
H2 114 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H3 115 F 31 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H4 116 F 59 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H5 117 F 60 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
H6 118 F 27 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4N1M0 Malignant
H7 119 F 59 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H8 120 F 58 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2NxM0 Malignant
H9 121 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H10 122 F 47 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
H11 123 F 58 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N2M0 Malignant
H12 124 F 46 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
H13 125 F 51 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H14 126 F 44 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H15 127 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
H16 128 F 62 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T3NxM0 Malignant
I1 129 F 40 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
I2 130 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
I3 131 F 45 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T3N1M0 Malignant
I4 132 F 52 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
I5 133 F 67 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
I6 134 F 60 Breast Chronic inflammation of skin tissue Malignant
I7 135 F 51 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I T2N0M0 Malignant
I8 136 F 41 Breast Breast tissue Malignant
I9 137 F 39 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
I10 138 F 52 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
I11 139 F 44 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T3N1M0 Malignant
I12 140 F 41 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2N0M0 Malignant
I13 141 F 43 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
I14 142 F 64 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4bNxM0 Malignant
I15 143 F 59 Breast Mucous carcinoma T2NxM0 Malignant
I16 144 F 42 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
J1 145 F 30 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T2NxM0 Malignant
J2 146 F 50 Breast Infiltrating micropapillary carcinoma T4bN1M0 Malignant
J3 147 F 41 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) II T4NxM0 Malignant
J4 148 F 45 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
J5 149 F 59 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
J6 150 F 66 Breast Infiltrating lobular carcinoma T2N0M0 Malignant
J7 151 F 47 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
J8 152 F 50 Breast A little cancer nodule in fatty tissue T2NxM0 Malignant
J9 153 F 59 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
J10 154 F 61 Breast Infiltrating lobular carcinoma T4NxM0 Malignant
J11 155 F 35 Breast Infiltrating lobular carcinoma T3NxM0 Malignant
J12 156 F 68 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
J13 157 F 40 Breast Breast tissue Malignant
J14 158 F 30 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
J15 159 F 53 Breast Infiltrating lobular carcinoma T4bN1M0 Malignant
J16 160 F 58 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K1 161 F 39 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K2 162 F 71 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K3 163 F 52 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K4 164 F 51 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K5 165 F 47 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K6 166 F 52 Breast Infiltrating lobular carcinoma T3NxM0 Malignant
K7 167 F 52 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K8 168 F 50 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K9 169 F 33 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K10 170 F 68 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K11 171 F 47 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K12 172 F 46 Breast Infiltrating lobular carcinoma T4N0M0 Malignant
K13 173 F 55 Breast Infiltrating lobular carcinoma T2N0M0 Malignant
K14 174 F 48 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
K15 175 F 45 Breast Infiltrating lobular carcinoma T1NxM0 Malignant
K16 176 F 47 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
L1 177 F 70 Breast Infiltrating lobular carcinoma T2N1M0 Malignant
L2 178 F 47 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
L3 179 F 58 Breast Breast tissue with epithelium hyperplasia Malignant
L4 180 F 49 Breast Infiltrating lobular carcinoma T3N1M0 Malignant
L5 181 F 37 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
L6 182 F 39 Breast Breast tissue Malignant
L7 183 F 49 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
L8 184 F 46 Breast Breast tissue Malignant
L9 185 F 44 Breast Infiltrating lobular carcinoma T2N0M0 Malignant
L10 186 F 58 Breast Infiltrating lobular carcinoma T2N0M0 Malignant
L11 187 F 38 Breast Infiltrating lobular carcinoma T2N0M0 Malignant
L12 188 F 56 Breast Infiltrating lobular carcinoma T2N0M0 Malignant
L13 189 F 43 Breast Infiltrating lobular carcinoma T1cN0M0 Malignant
L14 190 F 39 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
L15 191 F 58 Breast Infiltrating lobular carcinoma T3N1M0 Malignant
L16 192 F 52 Breast Infiltrating lobular carcinoma T2NxM0 Malignant
M1 193 F 47 Breast Breast tissue of No. 151 Normal
M2 194 F 46 Breast Breast tissue of No. 172 Normal
M3 195 F 46 Breast Breast tissue of No. 152 Normal
M4 196 F 41 Breast Fibrous tissue Normal
M5 197 F 49 Breast Breast tissue Normal
M6 198 F 46 Breast Breast tissue Normal
M7 199 F 38 Breast Fibrofatty tissue of No. 187 Normal
M8 200 F 50 Breast Infiltrating duct carcinoma, not otherwise specified (NOS) I Normal


"-" No grading available, *Tissue dots may be missing or histologically unidentifiable. † For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.


Find overlapping cases with this tissue array: